Literature DB >> 9383458

A novel RNA motif for neomycin recognition.

M G Wallis1, U von Ahsen, R Schroeder, M Famulok.   

Abstract

BACKGROUND: Antibiotics can interfere with RNA activity. Translation of RNA by the prokaryotic ribosome, self-splicing of group I introns, HIV replication and hammerhead ribozyme cleavage are inhibited by the aminoglycoside neomycin B. To explore the molecular basis by which small molecules such as antibiotics inhibit RNA function, we undertook an in vitro selection to obtain a variety of RNA molecules with the capacity to recognize neomycin.
RESULTS: The majority of the RNA molecules selected to specifically bind neomycin share a region of nucleotide sequence homology. From chemical probing and covariations among different clones we show that in all sequences this region folds into a hairpin structure, which from footprinting and partial alkaline hydrolysis experiments is shown to be the neomycin-binding site. Neomycin is recognized with high affinity (Kd approximately equal to 100 nM) and high specificity (> 100-fold higher affinity for neomycin than for paromomycin).
CONCLUSIONS: The fact that RNAs containing the consensus sequence, as well as sequences that display variations within this region, specifically recognize neomycin suggests that a structural motif rather than a particular nucleotide sequence is required for neomycin recognition. We propose that a hairpin stem-loop structural motif, which might feature a widened major groove, may be a prerequisite for neomycin recognition. This structural pattern can be extrapolated to other natural neomycin-responsive RNAs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9383458     DOI: 10.1016/1074-5521(95)90188-4

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  36 in total

Review 1.  Colorimetric biosensors based on DNAzyme-assembled gold nanoparticles.

Authors:  Juewen Liu; Yi Lu
Journal:  J Fluoresc       Date:  2004-07       Impact factor: 2.217

2.  Complete thermodynamic characterization of the multiple protonation equilibria of the aminoglycoside antibiotic paromomycin: a calorimetric and natural abundance 15N NMR study.

Authors:  Christopher M Barbieri; Daniel S Pilch
Journal:  Biophys J       Date:  2005-12-02       Impact factor: 4.033

3.  Screening for engineered neomycin riboswitches that control translation initiation.

Authors:  Julia E Weigand; Martin Sanchez; Ewald-Bernd Gunnesch; Sabrina Zeiher; Renee Schroeder; Beatrix Suess
Journal:  RNA       Date:  2007-11-13       Impact factor: 4.942

4.  Recombination, RNA evolution, and bifunctional RNA molecules isolated through chimeric SELEX.

Authors:  D H Burke; J H Willis
Journal:  RNA       Date:  1998-09       Impact factor: 4.942

5.  An antibiotic-binding motif of an RNA fragment derived from the A-site-related region of Escherichia coli 16S rRNA.

Authors:  H Miyaguchi; H Narita; K Sakamoto; S Yokoyama
Journal:  Nucleic Acids Res       Date:  1996-10-01       Impact factor: 16.971

6.  Selective transformations of complex molecules are enabled by aptameric protective groups.

Authors:  Andreas A Bastian; Alessio Marcozzi; Andreas Herrmann
Journal:  Nat Chem       Date:  2012-07-22       Impact factor: 24.427

Review 7.  Carbohydrate recognition by boronolectins, small molecules, and lectins.

Authors:  Shan Jin; Yunfeng Cheng; Suazette Reid; Minyong Li; Binghe Wang
Journal:  Med Res Rev       Date:  2010-03       Impact factor: 12.944

8.  Reprogramming bacteria to seek and destroy an herbicide.

Authors:  Joy Sinha; Samuel J Reyes; Justin P Gallivan
Journal:  Nat Chem Biol       Date:  2010-05-09       Impact factor: 15.040

9.  Selecting RNA aptamers for synthetic biology: investigating magnesium dependence and predicting binding affinity.

Authors:  James M Carothers; Jonathan A Goler; Yuvraaj Kapoor; Lesley Lara; Jay D Keasling
Journal:  Nucleic Acids Res       Date:  2010-02-16       Impact factor: 16.971

10.  Aminoglycosides: molecular insights on the recognition of RNA and aminoglycoside mimics.

Authors:  Maruthi Chittapragada; Sarah Roberts; Young Wan Ham
Journal:  Perspect Medicin Chem       Date:  2009-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.